Introduction
While the objective of malaria control programme is complete elimination, accurate identification of Plasmodium parasite becomes important exigently. [1] Microscopic examination of thick blood spots (TBS) still remains the method of choice for malaria diagnosis throughout malaria endemic areas; however, sometimes microscopy fails to detect malaria parasite at species level. Polymerase chain reaction (PCR) assay for malaria parasite detection has been proven useful as compared to the rapid diagnostic tests and microscopy. [2, 3] Nevertheless, use of PCR in routine diagnosis of malaria is practically difficult due to various reasons, but it could be useful for retrospective analysis of archived blood spots from the areas that lack proper infrastructure for storage and transport of collected blood samples. [4, 5] In the recent years, PCR assays that allow the identification and differentiation of all known Plasmodium species have been found sensitive for malaria diagnosis at species level, [2, 3, [6] [7] [8] but the current optimised PCR assay successfully amplified the parasite DNA from 2 year old experimental Plasmodium falciparum samples that had different levels of parasitaemia.
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Brief Communication April-June 2016 www.ijmm.org described elsewhere [7] with slight modifications in the reaction conditions. [9] PCR amplification was performed by targeting the small subunit of the ribosomal ribonucleic acid (18s rRNA) gene of P. falciparum as described in previous studies. [7, 9, 10] Five randomly selected samples from each of the six groups were used for PCR assay. The DNA extracted from the blood of one of the investigators was used as negative control, while that from a confirmed negative blood smear was used as a placebo control in the PCR assays.
Results
Of the total 129 human blood samples used in this study, 66 (51.2%) belonged to males and 68 (52.1%) had P. falciparum mono-infection. Mean age of the TBS-holders was 14.3 ± 1.1 (95% CI 12.1-16.5), while mean parasitaemia due to P. falciparum (n = 129) and Plasmodium vivax (n = 61) was 19,936.9 ± 2354.2 (95% CI: 15,323.0-24,551.0) and 1903.3 ± 250.4 (95% CI: 1402.6-2404.0), respectively [ Table 1 ]. The parasitaemia due to P. falciparum was significantly high as compared to P. vivax (P > 0.0001; t = 5.3), whereas no difference was observed between the parasitaemia level among both the sexes (P = 0.95; t = 0.06). The primary PCR assay used for the identification of Plasmodium genus amplified DNA in all the samples. However, the identification of P. falciparum species was achieved for all the samples, except three samples from group 'f' using nested PCR assay [ Figure 1 ]. These three samples did not show any amplification even after repeating the PCR several times.
Discussion
Many PCR assays have been employed to identify the malaria parasite DNA from blood samples, but none of the studies have demonstrated the amplification of DNA from long stored deteriorated P. falciparum blood smears having parasitaemia below 10 parasites/μl of blood. [2, 3, [9] [10] [11] [12] In this study, our main objective was to standardise a simple PCR assay that could amplify malaria parasite from archived damaged blood spots. We have successfully amplified both P. falciparum and P. vivax DNA in the samples, however, owing to the wide range of parasitaemia in P. falciparum; only P. falciparum samples were used to establish that current optimised PCR assay was able to amplify parasite DNA at very low levels of parasitaemia.
The PCR assay used in this study successfully amplified P. falciparum in 2 year old deteriorated blood spots having very low parasitaemia of up to ~10 parasites/μl of blood. Malaria intervention, particularly in low-transmission and elimination settings, largely depends upon accurate surveillance using sensitive diagnostic methods. PCR methods have been well-known to provide improved sensitivity and specificity as compared to microscopy and rapid diagnostic tests. [5, 9] Furthermore, the previous studies have also demonstrated the importance of PCR in detecting malaria parasite in dried blood samples as well as in infected mosquito specimens. [5, 10] However, this study has an advantage over the earlier studies that it used damaged and improperly stored blood spots which were actually discarded and lying unattended for the past 2 years.
Many malaria-endemic settings worldwide, including India, have insufficient health infrastructure to identify the actual malaria parasite in the field condition. Therefore, most of the time, new Plasmodium species remain undetected and later reported using molecular methods. [6, 8, 9, 11, 12] Sub-microscopic and asymptomatic infections of Plasmodium parasite largely remain unattended and serve as major drivers of malaria transmission in tropical settings. Some of these might be potentially more serious and even life-threatening, if not treated for a long time. The PCR assay employed currently identified all the P. falciparum samples but could not amplify DNA from few samples that have parasitaemia of ~ 1 parasite/μl of blood. We have used serially diluted DNA for making very low parasitaemia in a theoretical approach, however, with some modification and optimisation, the present assay could be more useful when performed using original samples having parasitaemia level of ~1 parasite/μl.
Conclusion
We have tested and proved a robust PCR-based assay for malaria parasite detection up to species level using deteriorated and long stored blood spots. Based on the present results, we propose a Plasmodium surveillance model in low malaria transmission settings where blood sample storage and transport facilities are scanty. The blood spots after microscopic examination for malaria could be kept aside in a box and later on sent to nearby PCR facility centre for correct identification to species level. This PCR assay might be used retrospectively to monitor invasion and prevalence of some new Plasmodium species in endemic areas.
